Ranking results:

Past rankings:

2020
Criterium:	Position:
Overall Score:	> 1000
Total Number of Projects:	> 1000
2019
Criterium:	Position:
Overall Score:	> 1000
Total Project Funding per Partner:	> 1000
Total Number of Projects:	> 1000
2014
Criterium:	Position:
Overall Score:	> 1000
Networking Rank (Reputation):	> 1000
2012
Criterium:	Position:
Overall Score:	> 1000
Networking Rank (Reputation):	> 1000
Networking Rank (Reputation):	> 1000
2011
Criterium:	Position:
Overall Score:	> 1000
Networking Rank (Reputation):	> 1000

Ranking timeline:

Project Participation Performance(2011-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 12
As coordinator: 2
As participant: 9
Sole participant: 1
Coordinator / Participant Ratio: 0.22^*

^*Ratio includes only projects with > 2 partners

Summary:

	Total project funding [€]:			Projects [No]:
Year:	coordinator^*	participant^*	per partner	as coordinator	as participant
2021	0	92.500.000	0		1
2020	0	89.815.600	0		1
2019	158.122	6.926.375	158.122	1	1
2017	5.819.416	0	1.923.768	1
2014	0	10.848.524	825.880		2
2012	0	8.248.559	738.987		3
2011	5.357.429	3.307.409	1.636.760	1	1

^*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:	Projects [No]:
FORSCHUNGSZENTRUM BORSTEL	4
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE	3
GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT NON PROFIT ORGANISATION	3
TASK FOUNDATION NPC	3
BIOASTER FONDATION DE COOPERATION SCIENTIFIQUE	2
CELLZOME	2
COMMISSARIAT A L'ENERGIE ATOMIQUE	2
CRITICAL PATH INSTITUTE LIMITED	2
DEPARTMENT OF HEALTH	2
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE	2
INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE	2
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE	2
INSTITUT PASTEUR	2
JANSSEN PHARMACEUTICA NV	2
UNIVERSIDAD DE ZARAGOZA	2
UNIVERSITY OF BIRMINGHAM	2
UNIVERSITY OF DUNDEE	2
UPPSALA UNIVERSITET	2
ACADEMISCH ZIEKENHUIS LEIDEN	1
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS	1
ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS	1
BILL & MELINDA GATES FOUNDATION	1
BIOVERSYS	1
CENTRE D'ETUDE ET DE RECHERCHES VETERINAIRES ET AGROCHIMIQUES	1
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS	1
CONSIGLIO NAZIONALE DELLE RICERCHE	1
CORIS BIOCONCEPT SPRL	1
DEUTSCHES ZENTRUM FUR INFEKTIONSFORSCHUNG EV	1
EUROPEAN LUNG FOUNDATION	1
EUROPEAN MOLECULAR BIOLOGY LABORATORY	1
EUROPEAN RESPIRATORY SOCIETY	1
EVOTEC INTERNATIONAL	1
FEDERAL STATE INSTITUTION SAINT PETERSBURG RESEARCH INSTITUTE OF PHTHISIOPULMONOLOGY OF THE FEDERAL AGENCY FOR HIGH TECHNOLOGY MEDICAL AID	1
FONDATION INNOVATIVE MEDICINES FOR TUBERCULOSIS (IM4TB)	1
FOUNDATION FOR INNOVATIVE NEW DIAGNOSTICS	1
FUNDACIO PRIVADA INSTITUT DE RECERCA DE L'HOSPITAL DE LA SANTA CREU I SANT PAU	1
FUNDACION CENTRO DE EXCELENCIA EN INVESTIGACION DE MEDICAMENTOS INNOVADORES EN ANDALUCIA	1
FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSIATRIO LA PAZ	1
GRITSYSTEMS AS	1
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT	1
IMABIOTECH SAS	1
INSERM TRANSFERT	1
INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT	1
INSTITUT PASTEUR DE LILLE	1
INSTITUT PASTEUR KOREA	1
INSTITUTO DE SAUDE PUBLICA DA UNIVERSIDADE DO PORTO	1
INTERVET INTERNATIONAL BV	1
JOHANN WOLFGANG GOETHE UNIVERSITAET FRANKFURT	1
KLINIKUM DER UNIVERSITAET ZU KOELN	1
KLINIKUM DER UNIVERSITAT MUNCHEN	1
KONINKLIJKE NEDERLANDSE CENTRALE VERENIGING TOT BESTRIJDING DER TUBERCULOSE	1
KUECEPT LIMITED	1
LATVIAN INSTITUTE OF ORGANIC SYNTHESIS	1
LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER	1
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN	1
LUND UNIVERSITY	1
LUNGS EUROPE	1
MEDICAL RESEARCH COUNCIL	1
NANOIMMUNOTECH SL	1
NANOLOGICA AB	1
NARODOWY INSTYTUT LEKOW	1
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE	1
OTSUKA NOVEL PRODUCTS	1
PROCARTA BIOSYSTEMS LIMITED	1
QPS NETHERLANDS BV	1
RUPRECHT KARLS UNIVERSITAET HEIDELBERG	1
SERVICIO MADRILENO DE SALUD	1
STICHTING HET NEDERLANDS KANKER INSTITUUTANTONI VAN LEEUWENHOEK ZIEKENHUIS	1
STICHTING KATHOLIEKE UNIVERSITEIT	1
STICHTING LYGATURE	1
STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM	1
STIFTELSEN SINTEF	1
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL	1
TECHNION ISRAEL INSTITUTE OF TECHNOLOGY	1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD	1
THE FEDERAL STATE SCIENTIFIC INSTITUTION SAINTPETERSBURG SCIENTIFIC RESEARCH PASTEUR INSTITUTE OF EPIDEMIOLOGY AND MICROBIOLOGY	1
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA	1
THE UNIVERSITY COURT OF THE UNIVERSITY OF ST ANDREWS	1
THE UNIVERSITY OF LIVERPOOL	1
THE UNIVERSITY OF SHEFFIELD	1
TUBERCULOSIS NETWORK EUROPEAN TRIALSGROUP EV	1
UNIVERSIDAD CARLOS III DE MADRID	1
UNIVERSITA DEGLI STUDI DI MILANO	1
UNIVERSITA DEGLI STUDI DI PADOVA	1
UNIVERSITA DEGLI STUDI DI PAVIA	1
UNIVERSITA VITASALUTE SAN RAFFAELE	1
UNIVERSITE DE MONTPELLIER	1
UNIVERSITE MONTPELLIER II	1
UNIVERSITE PIERRE ET MARIE CURIE PARIS VI	1
UNIVERSITEIT ANTWERPEN	1
UNIVERSITEIT LEIDEN	1
UNIVERSITEIT UTRECHT	1
UNIVERSITY COLLEGE LONDON	1
UNIVERSITY OF CAPE TOWN	1
UNIVERSITY OF COPENHAGEN	1
UNIVERSITY OF GLASGOW	1
UNIVERSITY OF HAMBURG	1
UNIVERSITY OF LANCASTER	1
UNIVERSITY OF LEEDS	1
UNIVERSITY OF TROMSOE	1

Constancy:

Total number of partners: 126
Partner loyalty:
Frequent Partner: (> 2 projects): 13
Rare Partner: 113
Frequent / Rare Partner Ratio: 0.12

Project overview:

Start date	Project	acronym	role	funding	partners
2021-06-01	ACADEMIA AND INDUSTRY UNITED INNOVATION AND TREATMENT FOR TUBERCULOSIS	UNITE4TB	participant	92.500.000	32
2020-01-01	EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS	ERA4TB	participant	89.815.600	33
2019-05-01	Boosting Ethionamide efficacy and lowering the dose with a small molecule transcriptional modulators, to overcoming MDR-TB infections and define a new place for Ethionamide in 1st-line TB treatments.	TRIC-TB	participant	6.926.375	2
2019-03-01	Development of lipid nanoparticles based on solid matrix for Benznidazole oral delivery targeting to the lymphatic system to treat Chagas disease	LYMPHVECs	coordinator	158.122	1
2017-01-01	AnTBiotic – progressing TB drug candidates to clinical proof of concept	anTBiotic	coordinator	5.819.416	5
2014-02-01	Nanotherapeutics for antibiotic resistant emerging bacterial pathogens	NAREB	participant	9.674.158	15
2014-02-01	Hit to lead optimisation of novel anti-TB scaffolds through an academic-industrial partnership	COOPERA-TB	participant	1.174.366	2
2012-10-01	Medicinal Chemistry Open Innovation Doctorates	OPENMEDCHEM	participant	690.111	2
2012-06-01	A systematic analysis of parasite metabolism - from metabolism to intervention	ParaMet	participant	3.816.703	12
2012-01-01	Training Network on Zebrafish Infection Models for Pharmaceutical Screens	FishForPharma	participant	3.741.745	10
2011-11-01	European Research Training in the Ubiquitin Proteasome System	UPStream	participant	3.307.409	10
2011-01-01	Open Collaborative Model for Tuberculosis Lead Optimisation	ORCHID	coordinator	5.357.429	14

Alias institution names:

GLAXOSMITHKLINE INVESTIGACION Y DESARROLLO SL

GLAXOSMITHKLINE INVESTIGACION Y DESARROLLO SL - Spain